MarketPulse

pediatric indication

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

BioCryst Achieves Historic Profitability as ORLADEYO Revenue Surges 38%

BioCryst achieved historic profitability with ORLADEYO revenue surging 38% to $601.8 million. FDA approval for pediatric formulation and Astria acquisition expand HAE treatment portfolio.
BCRXFDA approvalprofitability
BenzingaBenzinga··Vandana Singh

Merck Seeks to Expand RSV Antibody Approval Following Positive Phase 3 Trial Results

Merck's RSV antibody Enflonsia shows positive Phase 3 results, supporting FDA expansion plans to protect more at-risk infants from respiratory syncytial virus infection.
MRKGSKmonoclonal antibodyFDA approval